-

Everlywell Launches Next-Gen AI Health Platform Eva to Power Smarter, Scalable Care

Enterprise-ready AI solution built with Everlywell’s signature speed and precision

AUSTIN, Texas--(BUSINESS WIRE)--Everlywell, a leader in digital health, today announced the launch of Eva—an AI-powered platform that turns complex biomarker data into easy-to-understand, personalized health insights. Eva combines intelligence with engaging tools to guide and motivate individuals to take meaningful action for their health.

Eva is an intelligent health companion that helps personalize crucial touchpoints with smart recommendations and insights throughout the healthcare journey, including an AI-powered engagement model, care plans and clinician support, and CX agent:

  • Eva Engage: AI-powered proactive outreach that connects people at the right time with the right care, automatically scaling personalized health engagement for enterprise partners, including health plans and employers.
  • Eva Care: Smart care coordination that helps create personalized treatment pathways and connects people seamlessly with Everlywell's affiliated provider network.
  • Eva Support: Comprehensive AI navigator that instantly handles product questions, technical support, account management, and customer service needs.

Designed to reshape how and where healthcare happens, Eva integrates diagnostics, virtual care, and engagement into one seamless, end-to-end experience. With billions of engagement data points, Everlywell’s platform powers predictive outreach and dynamic care plans—fueling measurable outcomes for consumers and efficiency for enterprise partners. Later this year, Everlywell will expand Eva’s capabilities to streamline clinician workflows, including clinical charting and documentation.

For enterprise partners, Eva will guide a member through their entire care journey. A member who has never measured their blood pressure before, for example, can be engaged with personalized communications from Eva Engage, guided to the right blood pressure monitoring device by Eva Care with results interpreted instantly and a tailored care plan from a clinician—all in one connected care journey with Eva.

“We defined accessible, simple lab testing over the past decade—delivering health insights to 60 million Americans—and now we’re deploying the intelligence layer that healthcare has been missing,” said Julia Cheek, Founder and CEO of Everlywell. “This is proactive, personalized care powered by AI and grounded in clinical rigor. We’re not replacing human insight. We’re using AI-powered technology to scale it.”

Already embedded across Everlywell’s care ecosystem, Eva has delivered a measurable impact in patient engagement, clinical efficiency, and care gap closure. Everlywell 360 care plans are more insightful than ever with AI-enhanced, clinician-reviewed insights, and consumer engagement rates have more than doubled with Eva Support. For enterprise partners, this will mean higher return rates, lower costs per member, and a smooth experience that keeps patients engaged in their health journey—powered by machine learning models and voice agentic AI engagement.

With non-COVID enterprise revenue growing nearly 300% since 2020, Everlywell already delivers care to nearly 100 enterprise partners from health plans to diagnostic leaders. For our partners, Eva marks what’s next: AI-powered solutions that make care more connected, more effective, and more personalized.

About Everlywell

Everlywell is a digital health company pioneering the next generation of biomarker intelligence—combining AI-powered technology with human insight to deliver personalized, actionable health answers. Everlywell transforms complex biomarker data into life-changing insights—seamlessly integrating advanced diagnostics, virtual care, and patient engagement to reshape how and where health happens.

Over the past decade, Everlywell has delivered nearly 1 billion personalized health insights, transformed care for 60 million people and powered hundreds of enterprise partners, including 4 of the top 5 largest health plans in the U.S. that cover 170 million insured lives. In 2024 alone, an estimated 1 in 86 U.S. households received an Everlywell test, solidifying its spot as the #1 at-home testing brand in the country. Fueled by AI and built for scale, Everlywell is breaking down barriers, closing care gaps, and unlocking a more connected healthcare experience that is smarter, faster, and more personalized. Learn more at everlywell.com.

Contacts

Jensen Cannon, Everlywell
media@everlywell.com

Everlywell


Release Versions

Contacts

Jensen Cannon, Everlywell
media@everlywell.com

More News From Everlywell

On Inaugural National Get Tested Day, The American Sexual Health Association and Everlywell Partner to Provide Access to STI Testing

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--The American Sexual Health Association (ASHA), America’s nonprofit authority for sexual health information, is launching its inaugural National Get Tested Day on September 30 to advance the conversation around sexual health and break down barriers to accessing this essential health care. On the launch of National Get Tested Day, ASHA is partnering with Everlywell, a leader in at-home STI lab testing and treatment, to give away 250 free Everlywell a...

Everly Health and National Kidney Foundation Partnership Aims to Save Lives Through Early Detection of Chronic Kidney Disease

AUSTIN, Texas--(BUSINESS WIRE)--Everly Health, a leading remote-based healthcare company expanding access to virtual-first disease prevention, diagnosis, and treatment, today announced an educational partnership with the National Kidney Foundation aimed at informing Americans about chronic kidney disease and increasing access to screening in rural and underserved communities across the United States. Kidney disease affects 37 million adults in the United States but 90% are unaware they even hav...

Everly Health Selected to Participate in NCQA Virtual Care Pilot to Establish Quality Standards

AUSTIN, Texas--(BUSINESS WIRE)--Everly Health, a digital health platform for remotely diagnosing and managing recurring health conditions, is proud to announce its participation in the National Committee for Quality Assurance (NCQA) 2023 Virtual Care Pilot, an initiative that aims to define and elevate the standards of virtual care. After a competitive selection process—over 100 organizations applied—only a select group was chosen for the program. The NCQA Virtual Care Pilot presents a unique o...
Back to Newsroom